AI assistant
CITIGROUP INC — Capital/Financing Update 2011
Aug 23, 2011
14792_rns_2011-08-23_8c53cbab-8e9c-4ca7-8d3c-e20ad6cdecbc.zip
Capital/Financing Update
Open in viewerOpens in your device viewer
Issuer Free Writing Prospectus
Filed Pursuant to Rule 433
Registration Statement Nos. 333-172554 and 333-172554-01
| ● |
|---|
| Linked to the Common Stock of |
| Mosaic Company |
| Final Term Sheet |
| August 19, |
| 2011 |
| Issuer: | Citigroup Funding Inc. |
|---|---|
| Underlying Equity: | Mosaic Company (MOS) |
| Sole Manager: | Citigroup Global Markets Inc. |
| Offering: | 8.75% Synthetic Buy-Write (the Notes). |
| Offering Size: | USD 13,250,019.22 |
| Offering Price: | USD 66.58 |
| Units Issued: | 199,009 |
| Trade Date: | August 19, 2011 |
| Issue Date: | August 24, 2011 |
| Valuation Date: | February 17, 2012 |
| Maturity Date: | February 24, 2012 |
| Payment Days: | New York |
| Coupon: | 8.75% per annum payable quarterly (30/360 day count convention) |
| Coupon Payment Dates: | November 24, 2011; February 24, 2012. Any coupon payment on the Notes required to be made on a date that is not a Business Day need not be made on that date. A payment may be made on the next succeeding |
| Business Day with the same force and effect as if made on the specified date. | |
| Initial Equity Value: | USD 66.58 |
| Final Equity Value: | The closing value of the Underlying Equity on the Valuation Date |
| Cap Price: | USD 80.22 |
| Equity Ratio: | 1.0 share of the Underlying Equity for each buy-write of USD 66.58 principal amount with any fractional shares to be paid in |
| cash | |
| Payment at Maturity: | For each note of USD 66.58: |
| (a) If the Final Equity Value is greater than the Cap Price, then a cash amount equal to the Cap Price | |
| (adjusted for applicable dilution adjustments). | |
| (b) If the Final Equity Value is less than the Cap Price, then the cash equivalent of a number of | |
| shares equal to the Equity Ratio. |
Citigroup Funding Inc., the issuer, and Citigroup Inc., the guarantor, have filed a registration statement (including a prospectus supplement and prospectus) with the Securities and Exchange Commission (SEC) for the offering to which this communication relates. Before you invest, you should read the prospectus supplement and prospectus in that registration statement (File No. 333-172554) and the other documents Citigroup Funding and Citigroup Inc. have filed with the SEC for more complete information about Citigroup Funding, Citigroup Inc. and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov . Alternatively, you can request the prospectus supplement and prospectus by calling toll-free 1-877-858-5407.
8.75% Synthetic Buy-Write Notes Linked to the Common Stock of Mosaic Company Final Term Sheet August 19, 2011
| Form and Denomination: | Registered Medium Term Notes in minimum denominations and minimum increments of USD 66.58. |
|---|---|
| Cusip / ISIN: | 17317U667 / US17317U6670 |
| Calculation Agent: | Citigroup Global Markets Inc. |
| Listing: | None |
| Settlement: | DTC |
| Notice: | The Notes represent obligation of Citigroup Funding Inc. only and do not represent an obligation of or interest in MOS or any of its affiliates. MOS has not |
| authorized, sponsored or consented to the issuance of the Notes. |
Citigroup Funding Inc., the issuer, and Citigroup Inc., the guarantor, have filed a registration statement (including a prospectus supplement and prospectus) with the Securities and Exchange Commission (SEC) for the offering to which this communication relates. Before you invest, you should read the prospectus supplement and prospectus in that registration statement (File No. 333-172554) and the other documents Citigroup Funding and Citigroup Inc. have filed with the SEC for more complete information about Citigroup Funding, Citigroup Inc. and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov . Alternatively, you can request the prospectus supplement and prospectus by calling toll-free 1-877-858-5407.